Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

September 19, 2023

FFR-CT helps determine when CAD patients face a limited risk of adverse outcomes within 3 years

Researchers examined the "prognostic potential" of this advanced imaging modality. 

September 15, 2023
Ritu Thamman, MD, FASE, University of Pittsburgh School of Medicine, discusses trends and the technical aspects of strain imaging. #ASE #ASE23 #ASE2023 #strainecho

Strain imaging making a significant impact on the treatment of heart patients

Strain imaging has gained considerable momentum in recent years as an effective tool for getting more value out of heart evaluations. Ritu Thamman, MD, provided an in-depth look at the latest trends in strain echocardiography in an exclusive interview. 

September 14, 2023
Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment

Understanding reimbursements and coding for echocardiography

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

September 13, 2023
Arzhang Fallahi, MD, and David Hsi, MD, discussing imaging-based aortic stenosis screening

Q&A: Cardiologists explore the potential impact of a screening program for aortic stenosis

We already screen patients for breast cancer and lung cancer on a regular basis. Why not establish screening programs for aortic stenosis?

September 11, 2023
Jackie Sohn, DO, explains the use and trating requirements for intensivists and anesthesiologists to train on using point of care ultrasound (POCUS) at ASE 2023.

Training noncardiologists to perform basic POCUS exams

Jackie Sohn, DO, discussed how POCUS is now incorporated into fellowship training programs and the different ways these handheld and smaller cart-based systems are being utilized in hospitals.

September 11, 2023
Purvi Parwani, MD, director of echocardiography, Loma Linda University Medical Center, explains the trend where heart failure imaging guidelines are driving a rising use of mixed multimodality imaging. #ASE #ASE2023

Multimodality imaging helps cardiologists manage heart failure patients—with an assist from AI

Purvi Parwani, MD, discussed the trend toward multimodality imaging for heart failure management. All modalities have their own weaknesses, she explained. 

September 7, 2023
Example of the Siemens Origin AI-automated cardiac ultrasound system performing auto contours and measurements after the AI sees what is being imaged and the operator hits the AI button on the console. The system is designed to be an assistant to the operator and knows the next steps in the exams.

Siemens Healthineers unveils 'truly revolutionary' AI-enabled echo system

The new-look system is able to evaluate a situation and anticipate what users may need next.

August 25, 2023

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup